Alex Denner, PhD

Alex Denner
Source: Alex Denner
Alex Denner

Alex Denner, Ph.D., has been investing in health-care companies for the past two decades. In 2013 he founded Sarissa Capital Management LP, an investment fund, to capitalize on the compelling opportunities for positive shareholder activism created by the unique dynamics of the health-care sector. Sarissa focuses on improving the strategies of health-care companies to enhance shareholder value.

Denner has led Sarissa’s involvement in some of biopharma’s most successful strategic transactions and activist campaigns, including the sale of Idenix to Merck, the sale of ARIAD to Takeda, the spin-off from Biogen and subsequent sale of Bioverativ to Sanofi and the recent announcement by Ironwood Pharmaceuticals to separate its commercialized products business from its R&D platform, among others.

Prior to founding Sarissa, Denner was the health-care portfolio manager of Icahn Capital. At Icahn Capital, Denner developed Carl Icahn’s activist strategy in health care and was responsible for some of Icahn’s most successful investments, including ImClone, Genzyme, Amylin, Biogen and Forest Laboratories. In the decade prior to joining Icahn Capital, Denner honed his skills as a fundamental, value-based health-care investor first at Morgan Stanley Investment Management and then at Viking Global Investors.

Denner currently serves as a director of Biogen and a director and chairman of The Medicines Company. He previously served as a director and chairman of ARIAD Pharmaceuticals and director of Amylin Pharmaceuticals, Bioverativ and ImClone Systems, where he was also chairman of the executive committee.

Denner received his S.B. degree from the Massachusetts Institute of Technology and his M.S., M.Phil. and Ph.D. degrees from Yale University.

Previous Years

  • CNBC and Institutional Investor hosted the 7th Annual Delivering Alpha Conference on September 12, 2017.

  • Delivering Alpha 2017 stage, signage

    Meet the 2017 advisory board of Delivering Alpha, which takes place on September 12, 2017 at The Pierre in New York City.

  • The stage at Delivering Alpha 2016 in New York on Sept. 13, 2016.

    CNBC and Institutional Investor hosted the 6th Annual Delivering Alpha Conference on September 13, 2016.

About

CNBC and Institutional Investor are pleased to host the 8th Annual Delivering Alpha Conference in New York City on July 18, 2018. Please take note of the new month for 2018. Delivering Alpha continues to be an incomparable who’s who of the investor community with leading asset manager and institutional investors offering candid views along with illustrious political and economic commentators appearing in short segments moderated by CNBC talent and II editors.

To request additional information on Delivering Alpha, please contact lyao@ttivanguard.com.